Treatment of dystonia

被引:17
作者
Adam, Octavian R. [1 ,2 ]
Jankovic, Joseph [1 ,2 ]
机构
[1] Baylor Univ, Parkinsons Dis Ctr, Houston, TX 77030 USA
[2] Baylor Univ, Dept Neurol, Movement Disorders Clin, Houston, TX 77030 USA
关键词
dystonia; botulinum toxin; deep brain stimulation; treatment;
D O I
10.1016/S1353-8020(08)70031-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Dystonia varies in severity from simple focal dystonia, such as writer's cramp to life-threatening status dystonicus. Even though the pathophysiology is still elusive, symptomatic treatments may provide marked relief. Botulinum toxin is considered the treatment of choice for most focal and segmental dystonias. Deep brain stimulation of the basal ganglia, particularly the globus pallidus internum, is emerging as an important treatment for refractory, generalized, and segmental forms of dystonia. Gene therapy is also being explored as a possible treatment of inherited dystonias. This article reviews the therapeutic options available for the various types of dystonia. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:S362 / S368
页数:7
相关论文
共 27 条
[1]
Unilateral versus bilateral injections of botulinum toxin in patients with adductor spasmodic dysphonia [J].
Bielamowicz, S ;
Stager, SV ;
Badillo, A ;
Godlewski, A .
JOURNAL OF VOICE, 2002, 16 (01) :117-123
[2]
Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia [J].
Comella, CL ;
Jankovic, J ;
Shannon, KM ;
Tsui, J ;
Swenson, M ;
Leurgans, S ;
Fan, W .
NEUROLOGY, 2005, 65 (09) :1423-1429
[3]
Suicide after deep brain stimulation of the internal globus pallidus for dystonia [J].
Foncke, EMJ ;
Schuurman, PR ;
Speelman, JD .
NEUROLOGY, 2006, 66 (01) :142-143
[4]
Pallidal high-frequency deep brain stimulation for camptocormia: an experience of three cases [J].
Fukaya, C. ;
Otaka, T. ;
Obuchi, T. ;
Kano, T. ;
Nagaoka, T. ;
Kobayashi, K. ;
Oshima, H. ;
Yamamoto, T. ;
Katayama, Y. .
ADVANCES IN FUNCTIONAL AND REPARATIVE NEUROSURGERY, 2006, 99 :25-28
[5]
Silencing primary dystonia: Lentiviral-mediated RNA interference therapy for DYT1 dystonia [J].
Gonzalez-Alegre, P ;
Bode, N ;
Davidson, BL ;
Paulson, HL .
JOURNAL OF NEUROSCIENCE, 2005, 25 (45) :10502-10509
[6]
Intrathecal baclofen for dystonia [J].
Hou, JGG ;
Ondo, W ;
Jankovic, J .
MOVEMENT DISORDERS, 2001, 16 (06) :1201-1202
[7]
Long-term outcome of bilateral pallidal deep brain stimulation for primary cervical dystonia [J].
Hung, S. W. ;
Hamani, C. ;
Lozano, A. M. ;
Poon, Y. -Y. W. ;
Piboolnurak, P. ;
Miyasaki, J. M. ;
Lang, A. E. ;
Dostrovsky, J. O. ;
Hutchison, W. D. ;
Moro, E. .
NEUROLOGY, 2007, 68 (06) :457-459
[8]
Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystonia [J].
Jankovic, J. ;
Hunter, C. ;
Dolimbek, B. Z. ;
Dolimbek, G. S. ;
Adler, C. H. ;
Brashear, A. ;
Comella, C. L. ;
Gordon, M. ;
Riley, D. E. ;
Sethi, K. ;
Singer, C. ;
Stacy, M. ;
Tarsy, D. ;
Atassi, M. Z. .
NEUROLOGY, 2006, 67 (12) :2233-2235
[9]
Botulinum toxin in clinical practice [J].
Jankovic, J .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2004, 75 (07) :951-957
[10]
Treatment of dystonia [J].
Jankovic, Joseph .
LANCET NEUROLOGY, 2006, 5 (10) :864-872